Журнал неонатальной биологии

Абстрактный

Minimally Invasive Surfactant Therapy: New Age

Francisco José Canals Candela, Carolina Vizcaíno Díaz, María Jesús Ferrández Berenguer, María Isabel Serrano Robles, Consuelo Vázquez Gomis and José Luís Quiles Durá

For many years preterm infants with respiratory distress syndrome (RDS) have been managed with intubation and surfactant administration, but advances in Neonatology have allowed a softer therapy in newborns. The use of non-invasive respiratory support has been widespread. This has implied that surfactant administration, linked to mechanical ventilation, is just used in cases of non-invasive respiratory support failure. Nowadays Minimally Invasive Surfactant Therapy (MIST) allows neonatologists to use surfactant administration with non-invasive respiratory support. MIST techniques by tracheal catheterization have shown good results reducing the need of mechanical ventilation, bronchopulmonary dysplasia and improved oxygenation. These techniques are safe, effective, gentle and feasible to perform in all level NICUs.